Toggle navigation
ABOUT US
Overview
Leadership
Governance
Board
Our purpose
Global footprint
Our global reach
Partners
Press releases
News
Our science
Drug optimization
Lauriad
®
technology
Overview
How it works
Scientific publications
Lauriad
®
applications
OUR MEDICINES
PIPELINE
Commercialized medicines
Sitavig
®
Loramyc
®
PARTNER WITH US
Commercial & Industrial partners
Academic & Research collaborations
Careers
Working at Vectans Pharma
Join us
CONTACT
News
A common goal, to improve the lives of patients
OTC switch approval in Sweden for Virono®50mg
A brighter horizon for Oropharyngeal Candidiasis patients in Argentina
Loramyc® Marketing autorization granted in mexico !
Happy 2024 !
OTC switch approval in Finland for Sitavig® 50mg
Exclusive agreement with the Menarini group and Berlin Chemie
Season's greetings
Vectans Pharma participated in a symposium about new treatments in Oropharyngeal Candidiasis
1
2
→
230 Bureaux de la colline
92213 Saint-Cloud
France
contact@vectans.com
FOLLOW US
Copyright © VECTANS PHARMA
Legal notices and privacy policy
